Contents
Foreword
Leonard Girnita
Associate Professor of Pathology, Department of Oncology/Pathology, Karolinska Institute
Current Issues
Novel Therapies
Survivin-directed Anticancer Therapies – A Review of Pre-clinical Data and Early-phase Clinical Trials
Helen Doolittle,1
Armand Morel2 and Denis Talbot3
1. Researcher, North West Thames Academic Foundation Programme, Hammersmith Hospital, Imperial College, London; 2. Clinical Research Assistant, Oxford Lung Cancer Group, Churchill Hospital, University of Oxford; 3. Consultant Medical Oncologist, and Reader, Oxford Cancer Centre, University of Oxford
Cancer Prevention
Budesonide versus Placebo in a High-risk Population with Screen-detected Lung Nodules
Matteo Lazzeroni,1
Giulia Veronesi2 and Bernardo Bonanni3
1. Medical Oncology Resident, Division of Cancer Prevention and Genetics; 2. Director, Lung Cancer Early Detection Unit, Department of Thoracic Surgery; 3. Director, Division of Cancer Prevention and Genetics, European Institute of Oncology
Supportive Oncology
The Use of Patient-reported Outcomes at an Individual Level – Benefits and Challenges
Agnes Czimbalmos1
and Andrew Bottomley2
1. Research Fellow; 2. Assistant Director and Head, Quality of Life Department, European Organisation for Research and Treatment of Cancer
Local Control of Metastatic Spinal Cord Compression Following Radiotherapy
Dirk Rades1
and Steven E Schild2
1. Vice Chairman, and Full Professor of Radiation Oncology, Department of Radiation Oncology, University of Lubeck; 2. Chairman, and Professor, Department of Radiation Oncology, Mayo Clinic Arizona
The Neurogenic Component of Cutaneous Toxicities Induced by Chemotherapy – New Solutions
Jean-François Chanez
Head, Scientific Department, Evolife Laboratoires
Fertility Preservation Options for Patients with Cancer
Melissa C Hulvat1
and Jacqueline S Jeruss2
1. Breast-surgical Oncologist, and Co-Director, Bass Breast Center, Northwest Healthcare; 2. Assistant Professor, and Course Director, Surgical Ethics, Department of Surgery, Robert H Lurie Comprehensive Cancer Center and Lynn Sage Comprehensive Breast Center, Northwestern University Feinberg School of Medicine
Breast Cancer
Evolution of the 21-gene Assay Oncotype DX® from an Experimental Assay to an Instrument Assisting in Risk Prediction and Optimisation of Treatment Decision-making in Early Breast Cancer
Christian Jackisch,1
Michael Untch,2 Jens-Uwe Blohmer,3 Ulrike Nitz4 and Nadia Harbeck5
1. Professor of Gynaecology, and Head, Department of Obstetrics and Gynaecology and Breast Cancer Centre, Klinikum Offenbach; 2. Professor of Gynaecology, and Head, Department of Obstetrics and Gynaecology and Interdisciplinary Breast Cancer Centre, Helios Klinikum Berlin-Buch; 3. Professor of Gynaecology, and Head, Department of Obstetrics and Gynaecology and Breast Cancer Centre, Sankt Gertrauden Hospital, Berlin; 4. Professor of Gynaecology, and Head, Department of Senology, Bethesda Krankenhaus, Mönchengladbach; 5. Professor of Gynaecology, and Head, Breast Centre, University of Cologne
Head and Neck Cancer
Targeted Therapy in Combination with Chemotherapy in Recurrent and/or Metastatic Head and Neck Cancer
Pol Specenier1
and Jan B Vermorken2
1. Medical Oncologist; 2. Professor of Oncology, and Head, Department of Medical Oncology, Antwerp University Hospital
4
43 36 31 28 24 19 15 10 8
EUROPEAN ONCOLOGY
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100